Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04568096 |
|---|---|
| Brief Title: | Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19 |
| First Submitted : | September 26, 2020 |
| First Submitted that Met QC Criteria : | September 26, 2020 |
| First Posted : | September 29, 2020 |
| Last Update Submitted that Met QC Criteria : | October 23, 2020 |
| Last Update Posted : | October 26, 2020 |